Nassim Usman
Chief Executive Officer, GYRE THERAPEUTICS, INC.
Companies
- GYRE THERAPEUTICS, INC.Board member Aug 20, 2015 to Jul 1, 20241
- GYRE THERAPEUTICS, INC.Chief executive officer Aug 20, 2015 to Sep 1, 20231
- GYRE THERAPEUTICS, INC.President Aug 20, 2015 to Sep 1, 20231
- Principia Biopharma (United States)Board member Sep 13, 2018 to Sep 13, 20182
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- GYRE THERAPEUTICS, INC. GYRE1,713 shares3$11.0K at $6.40Jul 1, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 28, 2024Sold 3,452 shares at $12.00 of GYRE THERAPEUTICS, INC.3
- Jun 28, 2024Exercised options 3,452 shares at $6.93 of GYRE THERAPEUTICS, INC.3
- May 1, 2024Sold 100 shares at $15.63 of GYRE THERAPEUTICS, INC.4
- May 1, 2024Sold 5,000 shares at $14.90 of GYRE THERAPEUTICS, INC.4
- May 1, 2024Sold 14,900 shares at $13.86 of GYRE THERAPEUTICS, INC.4
- May 1, 2024Exercised options 20,000 shares at $6.93 of GYRE THERAPEUTICS, INC.4
- Apr 1, 2024Sold 20,000 shares at $16.15 of GYRE THERAPEUTICS, INC.5
- Apr 1, 2024Exercised options 20,000 shares at $6.93 of GYRE THERAPEUTICS, INC.5
- Mar 15, 2024Sold 20,000 shares at $17.26 of GYRE THERAPEUTICS, INC.6
- Mar 15, 2024Exercised options 20,000 shares at $6.93 of GYRE THERAPEUTICS, INC.6
- Aug 31, 2023Returned to company 1 shares of GYRE THERAPEUTICS, INC.7
- Aug 31, 2023Returned to company 8 shares of GYRE THERAPEUTICS, INC.7
- Aug 31, 2023Returned to company 25 shares of GYRE THERAPEUTICS, INC.7
- Aug 9, 2022Bought 3,250 shares at $0.47 of GYRE THERAPEUTICS, INC.8
- Feb 9, 2022Bought 3,250 shares at $0.46 of GYRE THERAPEUTICS, INC.9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed May 2, 2024
- 5SEC EDGARForm 4 filed Apr 3, 2024
- 6SEC EDGARForm 4 filed Mar 19, 2024
- 7SEC EDGARForm 4 filed Sep 1, 2023
- 8SEC EDGARForm 4 filed Aug 10, 2022
- 9SEC EDGARForm 4 filed Feb 16, 2022